Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
Status:
Not yet recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
To study the in vivo expression of dopamine D2 receptors in nonfunctioning pituitary adenoma
and the predictive role of dopamine dopamine D2 receptors PET-MR imaging in the therapeutic
effect of dopamine agonists（DA）.
Phase:
N/A
Details
Lead Sponsor:
Zhebao Wu
Collaborators:
Beijing Tiantan Hospital Chinese PLA General Hospital First Affiliated Hospital of Fujian Medical University First Affiliated Hospital of Wenzhou Medical University First Hospital of China Medical University Huashan Hospital Peking Union Medical College Hospital Xinqiao Hospital of Chongqing